PHASE I TRIAL OF CARBOPLATIN, BEVACIZUMAB, AND TEMSIROLIMUS IN ADVANCED SOLID TUMORS

被引：0
|
作者：
Westin, S. [1 ]
Castaneda, M. [2 ]
Pal, N. [1 ]
Urbauer, D. [3 ]
Janku, F. [2 ]
Wheler, J. [2 ]
Piha-Paul, S. [2 ]
Naing, A. [2 ]
Tsimberidou, A. [2 ]
Fu, S. [2 ]
Hong, D. [2 ]
Subbiah, V. [2 ]
Zinner, R. [2 ]
Karp, D. [2 ]
Coleman, R. [2 ]
Moulder, S. [2 ]
Kurzrock, R. [4 ]
机构：
[1] UT MD Anderson Canc Ctr, Gynecol Oncol & Reprod Med, Houston, TX USA
[2] UT MD Anderson Canc Ctr, Invest Canc Therapeut, Houston, TX USA
[3] UT MD Anderson Canc Ctr, Biostat, Houston, TX USA
[4] Univ Calif San Diego, Hematol & Oncol, Houston, TX USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-0717
引用
收藏
页码：365 / 365
页数：1
相关论文
共 50 条
  • [41] Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors
    Mita, Monica
    Fu, Siqing
    Piha-Paul, Sarina Anne
    Janku, Filip
    Mita, Alain
    Natale, Ronald
    Guo, Wei
    Zhao, Charles
    Kurzrock, Razelle
    Naing, Aung
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (05) : 616 - 626
  • [42] Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors
    Fatima Rangwala
    Johanna C. Bendell
    Mark F. Kozloff
    Christy C. Arrowood
    Andrew Dellinger
    Jennifer Meadows
    Sandra Tourt-Uhlig
    Jennifer Murphy
    Kellen L. Meadows
    Aijing Starr
    Samuel Broderick
    John C. Brady
    Stephanie M. Cushman
    Michael A. Morse
    Hope E. Uronis
    S. David Hsu
    S. Yousuf Zafar
    James Wallace
    Alexander N. Starodub
    John H. Strickler
    Herbert Pang
    Andrew B. Nixon
    Herbert I. Hurwitz
    Investigational New Drugs, 2014, 32 : 700 - 709
  • [43] Phase I study of docetaxel and temsirolimus in refractory solid tumors
    Mwandoro, T. N.
    Gao, F.
    Lockhart, A. C.
    Suresh, R.
    Tan, B. R.
    Wang-Gillam, A.
    Fracasso, P. M.
    Picus, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors
    Monica Mita
    Siqing Fu
    Sarina Anne Piha-Paul
    Filip Janku
    Alain Mita
    Ronald Natale
    Wei Guo
    Charles Zhao
    Razelle Kurzrock
    Aung Naing
    Investigational New Drugs, 2017, 35 : 616 - 626
  • [45] A phase II trial of bevacizumab plus temsirolimus in patients with advanced hepatocellular carcinoma
    Knox, Jennifer J.
    Qin, Rui
    Strosberg, Jonathan R.
    Tan, Benjamin
    Kaubisch, Andreas
    El-Khoueiry, Anthony B.
    Bekaii-Saab, Tanios S.
    Rousey, Steven R.
    Chen, Helen X.
    Erlichman, Charles
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (01) : 241 - 246
  • [46] Phase I trial of gemcitabine and paclitaxel in advanced solid tumors
    Lim, N
    Lara, PN
    Lau, DHM
    Edelman, MJ
    Tanaka, M
    Al-Jazayrly, G
    Houston, J
    Lauder, I
    Gandara, DR
    CANCER INVESTIGATION, 2003, 21 (01) : 7 - 13
  • [47] Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors
    Amin, Manik
    Gao, Feng
    Terrero, Gretel
    Picus, Joel
    Wang-Gillam, Andrea
    Suresh, Rama
    Ma, Cynthia
    Tan, Benjamin
    Baggstrom, Maria
    Naughton, Michael J.
    Trull, Lauren
    Belanger, Stephanie
    Fracasso, Paula M.
    Lockhart, Albert Craig
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (09): : 443 - 448
  • [48] A phase II trial of bevacizumab plus temsirolimus in patients with advanced hepatocellular carcinoma
    Jennifer J. Knox
    Rui Qin
    Jonathan R. Strosberg
    Benjamin Tan
    Andreas Kaubisch
    Anthony B. El-Khoueiry
    Tanios S. Bekaii-Saab
    Steven R. Rousey
    Helen X. Chen
    Charles Erlichman
    Investigational New Drugs, 2015, 33 : 241 - 246
  • [49] A phase I study of temsirolimus and metformin in advanced solid tumours
    MacKenzie, Mary J.
    Ernst, Scott
    Johnson, Craig
    Winquist, Eric
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 647 - 652
  • [50] A phase I study of temsirolimus and metformin in advanced solid tumours
    Mary J. MacKenzie
    Scott Ernst
    Craig Johnson
    Eric Winquist
    Investigational New Drugs, 2012, 30 : 647 - 652
12345